Intellectual Property India Publishes Patent Application for 'A 3D-Printed Scaffold-Mediated Glioblastoma Spheroid Formation For Drug Screening Applications' Filed by Indian Council Of Medical Research; and Vellore Institute Of Technology

MUMBAI, India, April 10 -- Intellectual Property India has published a patent application (202411073879 A) filed by Indian Council Of Medical Research; and Vellore Institute Of Technology, New Delhi, on Sept. 30, 2024, for 'a 3d-printed scaffold-mediated glioblastoma spheroid formation for drug screening applications.'

Inventor(s) include Jaiswal, Amit Kumar; Manikandan, Ceera; and Iyer, Aakash Sambamoorthy.

The application for the patent was published on April 10, under issue no. 15/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to a biodegradable scaffold, a biodegradable scaffold mediated-cell spheroids and a process of preparation thereof. Particularly, the present invention relates to a process of preparation of a 3D-printed Polycaprolactone (PCL) scaffolds and 3D-printed Polycaprolactone (PCL) scaffolds-mediated glioblastoma (GBM) spheroids of various sizes. In said process glioblastoma cells are seeded on the 3D-printed Polycaprolactone (PCL) scaffolds with different pore dimensions, wherein highly controllable pore geometry and sizes of 3D-PCL scaffolds allow to monitor and direct the growth of glioblastoma (GBM) spheroids of different sizes with minimal fluctuation."

Disclaimer: Curated by HT Syndication.